Transcripts encoding three types of guanylyl-cyclase-coupled trans-membrane receptors in inner ear tissues of guinea pigs.
The distribution of membrane-bound guanylyl cyclase (GC) transcription in inner ear tissues of the guinea pig was addressed by a reverse transcription-PCR approach using consensus primers flanking a region of about 630 bp in the intracellular domains in the target sequences. Restriction mapping of such amplificates obtained from cochlear and vestibular specimens permitted us to demonstrate GC-A, GC-B, and GC-C expression by differentiating overall PCR signals. This assay indicated that GC-A was expressed in the cochlea and vestibular organ. PCR products resulting from transcripts of the GC-B gene were obtained at considerably lower abundance than amplificates typical of the GC-A gene. The consensus primer approach with subsequent restriction mapping provided the opportunity to examine at the same time expression of GC-C in the inner ear and revealed the occurrence of GC-C transcripts in both inner ear compartments under investigation. The distribution pattern found by analysing the intracellular domains of membrane-bound guanylyl cyclases was confirmed by demonstrating transcription of the corresponding extracellular receptor domains. In addition, single-strand conformation polymorphism analysis of cDNA amplificates comprising the catalytic domain of guanylyl cyclases also indicated the presence of GC-C expression in the inner ear tissues examined. The GC-C transcripts detected in inner ear tissues appeared to correlate with functional receptor expression, since the production of cyclic GMP catalyzed by cochlear and vestibular specimens was stimulated by 1 microM of heat-stable enterotoxin to 18 and 80% above basal levels, respectively. Thus, GC-C may be involved in the fluid regulation by typical ligands (e.g., the peptide hormone guanylin or the toxins causing travellers' diarrhea), not only in the intestine but also in the organs responsible for hearing and gravitational orientation.
Krause
G
G
Abteilung für Klinische Pharmakologie, Medizinische Klinik, Klinikum Innenstadt der Universität, Munich, Germany. 101 356.242@compuserve.com
Meyer zum Gottesberge
A M
AM
Wolfram
G
G
Gerzer
R
R
D000818:Animals; D009320:Atrial Natriuretic Factor / Q000378:metabolism; D001667:Binding, Competitive; D002462:Cell Membrane / Q000201:enzymology; D003051:Cochlea / Q000187:drug effects / Q000201:enzymology*; D018076:DNA, Complementary / Q000096:biosynthesis / Q000235:genetics; D004768:Enterotoxins; D004926:Escherichia coli; D015971:Gene Expression Regulation, Enzymologic / Q000235:genetics*; D006162:Guanylate Cyclase / Q000235:genetics / Q000378:metabolism*; D006168:Guinea Pigs; D016133:Polymerase Chain Reaction; D018807:Polymorphism, Single-Stranded Conformational; D012313:RNA / Q000378:metabolism; D015183:Restriction Mapping; D014158:Transcription, Genetic / Q000235:genetics*; D014722:Vestibule, Labyrinth / Q000187:drug effects / Q000201:enzymology*
D018076:DNA, Complementary; D004768:Enterotoxins; D012313:RNA; D009320:Atrial Natriuretic Factor; D006162:Guanylate Cyclase